EGFR and colorectal carcinoma: Mutations in the KRAS and B-RAF genes lead to hence constitutive activation of RAS/RAF proteins despite EGFR activation is blocked, and are considered to be an early event in CRC carcinogenesis with presence in about 20–50% cases [127,128].